L-arginine metabolism in breast cancer: mechanisms and therapeutic targets
-
By
-
Antonia Röglin
-
Rainer Böger
-
Juliane Hannemann
-
June 12, 2026
-
Clinical Scorecard: Metabolism of L-arginine in breast cancer: underlying mechanisms and potential therapeutic targets
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | L-arginine metabolism influences tumor growth, immune response, and metabolic signaling, highlighting its multifaceted role in breast cancer. |
| Target Population | |
| Care Setting | |
Key Highlights
- Resistance to therapy is a significant challenge in breast cancer management, emphasizing the need for metabolic reprogramming strategies.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
- Monitor for therapeutic resistance, disease progression, and consider L-arginine levels or related metabolic markers.
Risks
Patient & Prescribing Data
Women with various subtypes of breast cancer.
L-arginine metabolism may provide therapeutic targets, but results vary by subtype.
Clinical Best Practices
- Consider subtype-specific treatment approaches.
- Evaluate metabolic reprogramming in tumor cells for potential vulnerabilities.
- Research ongoing to define the role of L-arginine metabolism in breast cancer.
- Assess patient-specific metabolic profiles for tailored therapy.
Related Resources & Content
